Global Markets & Trade

We engage policymakers and industry partners globally to encourage the adoption of national laws and regulations to support the development of the biotechnology sector.  Pursuing biotechnology specific outcomes within new trade agreements and modernizing older agreements is important as the biotechnology sector is increasingly global, requiring rules to govern the trade in biotechnology product and foster cross-border collaboration.

Letters, Comments & Testimony
September 30, 2021
The undersigned organizations write to encourage policymakers to remove provisions in the Build Back Better Act that would curtail the effectiveness of Qualified Small Business Stock (QSBS) in incentivizing investment in innovative small businesses and startups.
July 15, 2021
As you prepare for Chancellor Merkel’s visit to Washington, we, the representatives of America’s biotechnology sector thought that you and your government might benefit from an update on all that our sector is doing globally to address the ongoing COVID crisis, and in particular to ensure that…
June 30, 2021
We would like to provide you some updates on the U.S. and global biotechnology industry’s efforts to scale-up global vaccine production to address the global imbalance in access to COVID vaccines, and to request a close working relationship with USTR now that the WTO has agreed to have text-based…